Long-term safety of infliximab for the treatment of inflammatory bowel disease: a single-centre cohort study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Long-term safety of infliximab for the treatment of inflammatory bowel disease: a single-centre cohort study

Published:2008-10-02 Issue:4 Volume:58 Page:501-508
ISSN:0017-5749
Container-title:Gut
language:en
Short-container-title:Gut

Author:

Fidder H,Schnitzler F,Ferrante M,Noman M,Katsanos K,Segaert S,Henckaerts L,Van Assche G,Vermeire S,Rutgeerts P

Publisher

BMJ

Subject

Gastroenterology

Cited by 388 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aktualisierte S3-Leitlinie „Diagnostik und Therapie des Morbus Crohn“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) (Version 4.1) – living guideline;Zeitschrift für Gastroenterologie;2024-08

2. Development of a Risk Prediction Model for Adverse Skin Events Associated with TNF-α Inhibitors in Rheumatoid Arthritis Patients;Journal of Clinical Medicine;2024-07-11

3. Case of autoimmune haemolytic anaemia, possibly secondary to vedolizumab in ulcerative colitis, successfully treated with rituximab;BMJ Case Reports;2024-06

4. Neurological disorders following the use of tumor necrosis factor-α inhibitors in inflammatory bowel disease patients: a real-world pharmacovigilance analysis;Expert Opinion on Drug Safety;2024-05-23

5. Anti–Tumor Necrosis Factor Therapy and Risk of Kidney Function Decline and Mortality in Inflammatory Bowel Disease;JAMA Network Open;2024-04-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP